Human antibodies to human IL-6 receptor

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S387900, C530S388220

Reexamination Certificate

active

08043617

ABSTRACT:
A human antibody or an antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KDof about 500 pM or less and blocks IL-6 activity with an IC50of 200 pM or less. In preferred embodiments, the antibody the antibody or antigen-binding fragment binds hIL-6R with an affinity at least 2-fold higher relative to its binding monkey IL-6R.

REFERENCES:
patent: 5480796 (1996-01-01), Kishimoto
patent: 5670373 (1997-09-01), Kishimoto
patent: 5795965 (1998-08-01), Tsuchiya
patent: 5817790 (1998-10-01), Tsuchiya
patent: 5888510 (1999-03-01), Kishimoto
patent: 5888511 (1999-03-01), Skurkovich et al.
patent: 6086874 (2000-07-01), Yoshida et al.
patent: 6261560 (2001-07-01), Tsujinaka et al.
patent: 6410691 (2002-06-01), Kishimoto
patent: 6692742 (2004-02-01), Nakamura et al.
patent: 6723319 (2004-04-01), Ito et al.
patent: 7320792 (2008-01-01), Ito et al.
patent: 2002/0187150 (2002-12-01), Mihara et al.
patent: 2004/0071706 (2004-04-01), Ito et al.
patent: 2004/0219156 (2004-11-01), Goldenberg et al.
patent: 2005/0142635 (2005-06-01), Tsuchiya
patent: 2005/0238644 (2005-10-01), Mihara et al.
patent: 2006/0078531 (2006-04-01), Sota
patent: 2006/0078532 (2006-04-01), Omoigui
patent: 2006/0078533 (2006-04-01), Omoigui
patent: 2006/0177436 (2006-08-01), Ghilardi et al.
patent: 2006/0251653 (2006-11-01), Okuda et al.
patent: 2006/0275294 (2006-12-01), Omoigui
patent: 2006/0292147 (2006-12-01), Yoshizaki et al.
patent: 2007/0036785 (2007-02-01), Kishimoto et al.
patent: 2007/0036788 (2007-02-01), Sheriff et al.
patent: 2007/0098714 (2007-05-01), Nishimoto et al.
patent: 2007/0148169 (2007-06-01), Yoshizaki et al.
patent: 2007/0280945 (2007-12-01), Stevens et al.
patent: 2008/0124325 (2008-05-01), Ito et al.
patent: 2008/0145367 (2008-06-01), Bove et al.
patent: 0 628 639 (1994-12-01), None
patent: 0409607 (1996-10-01), None
patent: 0 783 893 (1997-07-01), None
patent: 0 800 829 (1997-10-01), None
patent: 0 811 384 (1997-12-01), None
patent: 0 628 639 (1999-06-01), None
patent: 0 923 941 (1999-06-01), None
patent: 1 004 315 (2000-05-01), None
patent: 1 074 268 (2001-02-01), None
patent: 1 108 435 (2001-06-01), None
patent: 1 314 437 (2003-05-01), None
patent: 1 327 681 (2003-07-01), None
patent: 1 334 731 (2003-08-01), None
patent: 1 475 100 (2004-11-01), None
patent: 1 475 101 (2004-11-01), None
patent: 0 413 908 (2005-08-01), None
patent: 0 923 941 (2006-05-01), None
patent: 0 811 384 (2006-06-01), None
patent: 1 108 435 (2007-01-01), None
patent: 1 810 980 (2007-07-01), None
patent: 1 074 268 (2008-01-01), None
patent: 1 334 731 (2008-02-01), None
patent: 1 004 315 (2008-05-01), None
patent: 2694767 (1994-02-01), None
patent: WO 95/09873 (1995-04-01), None
patent: WO 2004/096273 (2004-11-01), None
patent: WO 2005/028514 (2005-03-01), None
patent: WO 2007/143168 (2007-12-01), None
patent: WO 2008/020079 (2008-02-01), None
patent: WO 2008/049897 (2008-05-01), None
patent: WO 2008/145142 (2008-12-01), None
patent: WO 2009/095489 (2009-08-01), None
patent: WO 2009/109584 (2009-09-01), None
Mihara et al. 2005. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. International Immunopharmacology 5:1731-1740.
Paul-Pletzer. 2006. Tocilizumab: Blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs of Today 42(9): 559-576.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human antibodies to human IL-6 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human antibodies to human IL-6 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human antibodies to human IL-6 receptor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4288281

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.